Navigation Links
Pittsburgh Life Sciences Greenhouse Announces the First Close of the PLSG Accelerator Fund LLC at $5 Million
Date:1/7/2011

PITTSBURGH, Jan. 7, 2011 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to the region's life sciences enterprises, issued this statement through its President and Chief Executive Officer, John W. Manzetti announcing the first close of the PLSG Accelerator Fund, LLC (Accelerator Fund) at $5 million.

The Accelerator Fund is being managed by the PLSG to make venture investments in life sciences companies located in western Pennsylvania. The Fund is targeting total capital commitments of $10 million which will be committed during an investment period of up to five years. It is expected that investments will represent life sciences companies from several sectors including medical devices, diagnostics, therapeutics, healthcare information technology and biotechnology tools. The Accelerator Fund will invest in companies that already have been vetted by the PLSG, through investment due diligence and mentoring from the PLSG's Executive Program.

"The region needs a life sciences venture investor, and the PLSG Accelerator Fund is the only pure life sciences venture fund in the region," said John W. Manzetti, PLSG President & CEO. "We have formed this fund as part of our commitment to create long term sustainability for our portfolio companies and provide needed capital for growing companies while offering fund investors the best opportunity for returns."

About the Pittsburgh Life Sciences Greenhouse (PLSG)The Pittsburgh Life Sciences Greenhouse (PLSG) provides capital investments and customized company formation and business growth services to western Pennsylvania's life sciences enterprises; connects investors with their Investment Portfolio companies; expands established life sciences ventures; and relocates biomedical companies to Pennsylvania. The PLSG supports biosciences companies with promising innovations in: Biotechnology Tools, Diagnostics, Healthcare IT, Medical Devices and Therapeutics. Since 2002, PLSG has worked with 320 companies and has made direct investments of $16.3 M in 60 companies which has leveraged over $500M in additional capital to the region. In addition, PLSG has invested $15.2M as a limited partner in two Pennsylvania venture capital firms which in turn invest in technology companies in the Commonwealth. To see the full portfolio and more information about PLSG visit www.plsg.com.Editors Note:Structure Traditional VC Model LLC Management Member (PLSG)Term 10 years
'/>"/>

SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals
2. The Pittsburgh Life Sciences Greenhouse Announces New Chairman of the Board
3. Precision Therapeutics President and CEO Sean McDonald Recognized as Pittsburgh Technology Council Tech 50 CEO of the Year
4. The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program
5. The Pittsburgh Life Sciences Greenhouse Invests $725K in Portfolio Companies
6. The Pittsburgh Life Sciences Greenhouse Adds Life Sciences Veterans to Executive Program
7. Pittsburgh Life Sciences Greenhouse Demonstrates a Regions Economic Resilience
8. The Pittsburgh Life Sciences Greenhouse Starts 2009 With Investment Momentum
9. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
10. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
11. Opening Dedication of the New John G. Rangos Sr. Research Center at the New Childrens Hospital of Pittsburgh of UPMC Campus in Lawrenceville
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory ... technical consulting, provides a free webinar on Performing Quality Investigations: Getting ... at 12pm CT at no charge. , Incomplete investigations are still a major ...
(Date:6/22/2016)... 22, 2016 Research and Markets has announced ... report to their offering. ... from $29.3 billion in 2013. The market is expected to grow ... 2015 to 2020, increasing from $50.6 billion in 2015 to $96.6 ... during the forecast period (2015 to 2020) are discussed. As well, ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
Breaking Biology News(10 mins):